Pulsenmore and Clalit Health collaborate for at-home follicular monitoring service for IVF, valued at $4.5 million over 5 years.
A commercial deal worth around $4.5 million is on the horizon for Pulsenmore Ltd. Following an 18-month pilot, this agreement is projected to span five years. The service is set to be rolled out through Beilinson NEXT, Beilinson's virtual hospital located in Ramat Gan, Israel. Pulsenmore Ltd., a global company listed on NASDAQ as PLSM and TASE as PLSM, announced the details on Jan. 26, 2026.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments